Passage Bio
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -177 | -200 | -201 | |
EBITDA | -10,163 | -7,439 | -9,185 | -13,621 |
EBIT | -10,340 | -7,749 | -9,385 | -13,822 |
Net Income | -12,983 | -7,749 | -9,385 | -15,405 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,479 | -4,853 | -6,330 | -13,847 |
Cash | 46,303 | 52,773 | 57,626 | 63,357 |
Basic Shares | 3,172 | 3,168 | 3,168 | 3,105 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -728 | -3,081 | -3,721 | -3,679 |
EBITDA | -42,423 | -62,086 | -98,341 | -131,715 |
EBIT | -43,151 | -65,167 | -102,062 | -135,394 |
Net Income | -45,522 | -64,767 | -102,062 | -136,125 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -94,364 | |||
Free Cash Flow | -31,509 | -47,990 | -78,410 | -123,484 |
Cash | 46,303 | 37,573 | 21,709 | 34,601 |
Basic Shares | 3,172 | 3,020 | 2,737 | 2,721 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$4.09 |
2025-09-30 | -$2.44 |
2025-06-30 | -$2.96 |
2025-03-31 | -$0.25 |
